Header links
Intranet
Donate now
image/svg+xml Map
Contact us

David Tabernero Caellas

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca
David Tabernero Caellas

David Tabernero Caellas

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Janna Anthonina Slabbekoorn

Janna Anthonina Slabbekoorn

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Maria Francesca Cortese

Maria Francesca Cortese

Main researcher
Microbiology
Read more
Efráin Santiago Cordero Vázquez

Efráin Santiago Cordero Vázquez

Predoctoral researcher
Diabetes and Metabolism
Read more
Matteo Pusceddu

Matteo Pusceddu

Postdoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.